Home › Cancer Genetics Expands BioDiscovery's Nexus Copy Number Platform to Identify Novel Biomarkers ...
 

Keywords :   


Cancer Genetics Expands BioDiscovery's Nexus Copy Number Platform to Identify Novel Biomarkers ...

2014-04-02 06:00:00| Industrial Newsroom - All News for Today

Hawthorne, CA and Rutherford, NJ &ndash; Cancer Genetics, Inc. (Nasdaq: CGIX) and BioDiscovery, Inc. have announced expansion of the Nexus Copy Number Discovery platform in CGI research to uncover novel biomarkers which are predictive of cancer outcomes.<br /> <br /> "Cancer Genetics has been able to leverage the Nexus Copy Number platform's unique ability to quickly digest large data sets to uncover correlations between genomic events and clinical factors in their discovery efforts," says ...This story is related to the following:Data Analysis Software |

Tags: number copy identify cancer

Category:Industrial Goods and Services

Latest from this category

All news
»
30.09Farm Progress America, September 30, 2024
30.09Tropical Depression Twelve Graphics
30.09Tropical Depression Joyce Graphics
30.09Tropical Storm Isaac Graphics
30.09Tropical Depression Twelve Forecast Discussion Number 3
30.09Tropical Depression Twelve Wind Speed Probabilities Number 3
30.09Tropical Depression Twelve Public Advisory Number 3
30.09Summary for Tropical Depression Twelve (AT2/AL122024)
More »